HPTN Publications

Hoddinott G, Myburgh H, de Villiers L, Ndubani R, Mantantana J, Thomas A, Mbewe M, Ayles H, Bock P, Seeley J, Shanaube K, Hargreaves J, Bond V, Reynolds L, HPTN 071 Study Team . Households, fluidity, and HIV service delivery in Zambia and South Africa - an exploratory analysis of longitudinal qualitative data from the HPTN 071 (PopART) trial. J Int AIDS Soc. 2018, 21 Suppl 4: e25135
Hofer CB, Harrison LH, Struchiner CJ, Moreira RI, do Lago RF, de Melo MF, Schechter M . Acute retrovirus syndrome among prospectively identified homosexual men with incident HIV infection in Brazil. The Projecto Praca Onze Study Group. Journal of Acquired Immune Deficiency Syndrome. J Acquir Immune Defic Syndr. 2000, 25: 188-91
Hoffman IF, Taha TE, Padian NS, Kelly CW, Welch JD, Martinson FE, Kumwenda NI, Rosenberg ZF, Chilongozi DA, Brown JM, Chirenje M, Richardson BA . Nonoxynol-9 100 mg gel: multi-site safety study from sub-Saharan Africa. AIDS. 2004, 18: 2191-5
Holden J, Goheen J, Jett-Goheen M, Barnes M, Hsieh YH, Gaydos CA . An evaluation of the SD Bioline HIV/syphilis duo test. Int J STD AIDS. 2018, 29: 57-62
Hsieh YH, Beck KJ, Rothman RE, Gauvey-Kern M, Woodfield A, Peterson S, Signer D, Gaydos CA . Factors associated with patients who prefer HIV self-testing over health professional testing in an emergency department-based rapid HIV screening program. Int J STD AIDS. 2017, 28: 1124-1129
Hsieh YH, Gaydos CA, Hogan MT, Jackman J, Jett-Goheen M, Uy OM, Rompalo AM . Perceptions on point-of-care tests for sexually transmitted infections – Comparison between frontline clinicians and professionals in industry. Point Care. 2012, 11: 126-9
Hsieh YH, Gaydos CA, Hogan MT, Uy OM, Jackman J, Jett-Goheen M, Albertie A, Dangerfield DT 2nd, Neustadt CR, Wiener ZS, Rompalo AM . What qualities are most important to making a point of care test desirable for clinicians and others offering sexually transmitted infection testing?. PLoS One. 2011, 6: e19263
Huang W, Eshleman SH, Toma J, Fransen S, Stawiski E, Paxinos EE, Whitcomb JM, Young AM, Donnell D, Mmiro F, Musoke P, Guay LA, Jackson JB, Parkin NT, Petropoulos CJ . Coreceptor tropism in human immunodeficiency virus type 1 subtype D: high prevalence of CXCR4 tropism and heterogeneous composition of viral populations. J Virol. 2007, 81: 7885-93
Huang W, Eshleman SH, Toma J, Stawiski E, Whitcomb JM, Jackson JB, Guay L, Musoke P, Parkin N, Petropoulos CJ . Vertical transmission of X4-tropic and dual-tropic HIV-1 in five Ugandan mother-infant pairs. AIDS. 2009, 23: 1903-8
Huang W, Toma J, Stawiski E, Fransen S, Wrin T, Parkin N, Whitcomb JM, Coakley E, Hecht FM, Deeks SG, Gandhi RT, Eshleman SH, Petropoulos CJ . Characterization of human immunodeficiency virus type 1 populations containing CXCR4-using variants from recently infected individuals. AIDS Res Hum Retroviruses. 2009, 25: 795-802
Hudelson SE, Marlowe N, Huang W, Bruce R, Church JD, Husnik M, Donnell D, Coates T, Jackson JB, Chesney M, Koblin B Eshleman SH . Analysis of HIV type 1 gp41 and enfuvirtide susceptibility among men in the United States who were HIV infected prior to availability of HIV entry inhibitors. AIDS Res Hum Retroviruses. 2009, 25: 701-5
Hudelson SE, McConnell MS, Bagenda D, Piwowar-Manning E, Parsons TL, Nolan ML, Bakaki PM, Thigpen MC, Mubiru M, Fowler MG, Eshleman SH . Emergence and persistence of nevirapine resistance in breast milk after single-dose nevirapine administration. AIDS. 2010, 24: 557-61
Hughes JP, Goldenberg R, Wilfert CM, Valentine M, Mwinga KG . Design of the HIV Prevention Trials Network (HPTN) Protocol 054: A cluster randomized crossover trial to evaluate combined access to nevirapine in developing countries. UW Biostatistics Working Paper Series. 2004, 195
Hughes JP, Haley DF, Golin CE, Adimora AA, Kuo I, Justman J, Soto-Torres L, Wang J, Hodder S . Regression to the mean and changes in risk behavior following study enrollment in a cohort of U.S. women at risk for HIV. 2015
Hughes JP, Richardson BA . Analysis of a randomized trial to prevent vertical transmission of HIV-1. JASA. 2000, 95: 1032-43
Hultin LE, Chow M, Jamieson BD, O'Gorman MRG, Menendez FA, Borowski L, Denny TN, and Margolick JB . Comparison of inter-laboratory variation in absolute T-cell counts by single-platform and optimized dual-platform methods. Cytometry Part B. 2010, 78: 194-200
Huppert JS, Hesse EA, Bernard MA, Xiao Y, Huang B, Gaydos CA, Kahn SA . Acceptability of self-testing for trichomoniasis increases with experience. Sex Transm Infect. 2011, 87: 494-500
Hussen SA, Stephenson R, Del Rio C, Wilton L, Wallace J, Wheeler D; HPTN 061 Protocol Team, Wheeler D, For the HPTN 061 Protocol Team . HIV Testing Patterns among Black Men Who Have Sex with Men: A Qualitative Typology. PLoS One. 2013, 8: e75382
Incidence Assay Critical Path Working Group . More and better information to tackle HIV epidemics: towards improved HIV incidence assays. PLoS Med. 2011, 8: e1001045
Irvin R, Vallabhaneni S, Scott H, Williams JK, Wilton L, Li X, Buchbinder S; HPTN 061, Buchbinder S, HPTN 061 . Examining Levels of Risk Behaviors among Black Men Who Have Sex with Men (MSM) and the Association with HIV Acquisition. PLoS One. 2015, 10: e0118281
Irvin R, Wilton L, Scott H, Beauchamp G, Wang L, Betancourt J, Lubensky M, Wallace J, Buchbinder S . A Study of Perceived Racial Discrimination in Black Men Who Have Sex with Men (MSM) and Its Association with Healthcare Utilization and HIV Testing. AIDS Behav. 2014, 18: 1272-8
Jackson B, Mmiro F, HIVNET 012 Study Team . HIVNET 012 and Petra (authors' reply). Lancet. 2004, 363: 244
Jackson JB, Barnett S, Piwowar-Manning E, Apuzzo L, Raines, C, Hendrix C, Hamzeh F, Gallant J . A Phase I/II study of nevirapine for pre-exposure prophylaxis of HIV-1 transmission in uninfected subjects at high risk. AIDS. 2003, 17: 547-53
Jackson JB, Becker-Pergola G, Guay LA, Musoke P, Mracna M, Fowler MG, Mofenson LM, Mirochnick M, Mmiro F, Eshleman SH . Identification of the K103N resistance mutation in Ugandan women receiving nevirapine to prevent HIV-1 vertical transmission. AIDS. 2000, 14: F111-5
Jackson JB, Musoke P, Fleming T, Guay LA, Bagenda D, Allen M, Nakabiito C, Sherman J, Bakaki P, Owor M, Ducar C, Deseyve M, Mwatha A, Emel L, Duefield C, Mirochnick M, Fowler MG, Mofenson L, Miotti P, Gigliotti M, Bray D, Mmiro F . Intrapartum and neonatal single-dose nevirapine compared with zidovudine for prevention of mother-to-child transmission of HIV-1 in Kampala, Uganda: 18-month follow-up of the HIVNET 012 randomised trial. Lancet. 2003, 362: 859-68
Jackson JB, Parsons T, Musoke P, Nakabiito C, Donnell D, Fleming T, Mirochnick M, Mofenson L, Fowler MG, Mmiro F, Guay L . Association of cord blood nevirapine concentration with reported timing of dose and HIV-1 transmission. AIDS. 2006, 20: 217-22 PMID: 16511414
Jackson JB, Wei L, Liping F, Aramrattana A, Celentano DD, Walshe L, Xing Y, Richardson P, Jun M, Beauchamp G, Donnell D, Ruan Y, Ma L, Metzger D, Shao Y . Prevalence and seroincidence of hepatitis B and hepatitis C infection in high risk people who inject drugs in china and Thailand. Hepat Res Treat. 2014, 2014: 296958
Jacob ST, Baeten JM, Hughes JP, Peinado J, Wang J, Sanchez J, Reid SE, Delany-Moretlwe S, Cowan F, Fuchs JD, Koblin B, Griffith S, Wald A, Celum C . A Post-Trial Assessment of Factors Influencing Study Drug
Adherence in a Randomized Biomedical HIV-1 Prevention Trial
. AIDS Behav. 2010, 15: 897-904
James MM, Laeyendecker O, Sun J, Hoover DR, Mullis CE, Cousins MM, Coates T, Moore RD, Kelen GD, Fowler MG, Kumwenda JJ, Mofenson LM, Kumwenda NI, Taha TE, Eshleman SH . Antibody maturation and viral diversification in HIV-infected women. PLoS One. 2013, 8: e57350
James MM, Wang L, Donnell D, Cousins MM, Barlow-Mosha L, Fogel JM, Towler WI, Agwu AL, Bagenda D, Mubiru M, Musoke P, Eshleman SH . Use of a high resolution melting assay to analyze HIV diversity in HIV-infected Ugandan children. Pediatr Infect Dis J. 2012, 31: e222-8
James MM, Wang L, Musoke P, Donnell D, Fogel J, Towler WI, Khaki L, Nakabiito C, Jackson JB, Eshleman SH . Association of HIV diversity and survival in HIV-infected Ugandan infants. PLoS One. 2011, 6: e18642
Janssen RS, Satten GA, Stramer SL, Rawal BD, O'Brien TR, Weiblen BJ, Hecht FM, Jack N, Cleghorn FR, Kahn JO, Chesney MA, Busch MP . New testing strategy to detect early HIV-1 infection for use in incidence estimates and for clinical and prevention purposes. JAMA. 1998, 280: 42-48
Jennings L, Pettifor A, Hamilton E, Ritchwood TD, Xavier Gomez-Olive F, MacPhail C, Hughes JP, Selin A, Kahn K, HPTN 068 Study Team . Economic Resources and HIV Preventive Behaviors Among School-Enrolled Young Women in Rural South Africa (HPTN 068). AIDS Behav. 2017, 21: 665-677
Jennings L, Rompalo AM, Wang J, Hughes J, Adimora AA, Hodder S, Soto-Torres LE, Frew PM, Haley DF; HIV Prevention Trials Network (HPTN 064) Women’s HIV SeroIncidence Study (ISIS), Haley DF, HIV Prevention Trials Network (HPTN 064) Women’s HIV SeroIncidence Study (ISIS), HIV Prevention Trials Network (HPTN 064) Women’s HIV SeroIncidence Study . Prevalence and Correlates of Knowledge of Male Partner HIV Testing and Serostatus Among African-American Women Living in High Poverty, High HIV Prevalence Communities (HPTN 064). AIDS Behav. 2015, 19: 291-301
Joglekar N, Joshi S, Kakde M, Fang G, Cianciola M, Reynolds S, Mehendale S; HIV Prevention Trial Network 047 Protocol Team . Acceptability of PRO2000 vaginal gel among HIV un-infected women in Pune, India. AIDS Care. 2007, 19: 817-21 PMID: 17573603
John GC, Sheppard H, Mbori-Ngacha D, Nduati R, Maron D, Reiner M, Kreiss J . Comparison of techniques for HIV-1 RNA detection and quantitation in cervicovaginal secretions. J Acquir Immune Defic Syndr. 2001, 26: 170-5
Jones D, Parkin N, Hudelson SE, Guay LA, Musoke P, Mmiro F, Jackson JB, Eshleman SH . Genetic linkage of nevirapine resistance mutations in HIV type 1 seven days after single-dose nevirapine. AIDS Res Hum Retroviruses. 2005, 21: 319-24
Joshi S, Dutta S, Bell B, Profy A, Kuruc J, Fang G, Cianciola M, Maslankowski L, Soto-Torres L, Panchanadikar A, Mehendale S, Reynolds SJ . Documenting intermenstrual bleeding in a vaginal microbicide study: case reports and lessons learned. AIDS Res Hum Retroviruses. 2006, 22: 294-6
Justman J, Befus M, Hughes J, Wang J, Golin CE, Adimora AA, Kuo I, Haley DF, Del Rio C, El-Sadr WM, Rompalo A, Mannheimer S, Soto-Torres L, Hodder S . Sexual Behaviors of US Women at Risk of HIV Acquisition: A Longitudinal Analysis of Findings from HPTN 064. AIDS Behavior. 2015, 19: 1327-37
Justman J, Goldberg A, Reed J, Bock N, Njeuhmeli E, Goldzier Thomas A . Adult male circumcision: reflections on successes and challenges. J Acquir Immune Defic Syndr. 2013, 63: S140-3
K Buchacz, J Farrior, G Beauchamp, L McKinstry, AE Kurth, BS Zingman, FM Gordin, D Donnell, KH Mayer, WM El-Sadr, B Branson . Changing Clinician Practices and Attitudes Regarding the Use of Antiretroviral Therapy for HIV Treatment and Prevention. J Int Assoc Physicians AIDS Care. 2017, 16: 81-90
K. Rivet Amico, Melissa Wallace, Linda-Gail Bekker, Surita Roux, Millicent Atujuna, Elaine Sebastian, Bonnie J. Dye, Vanessa Elharrar, Robert M. Grant, Amico KR, Wallace M, Bekker LG, Roux S, Atujuna M, Sebastian E, Dye BJ, Elharrar V, Grant RM . Experiences with HPTN 067/ADAPT Study-Provided Open-Label PrEP Among Women in Cape Town: Facilitators and Barriers Within a Mutuality Framework. AIDS and Behavior. 2017, 21: 1361-1375
Kafulafula G, Mwatha A, Chen YQ, Aboud S, Martinson F, Hoffman I, Fawzi W, Read JS, Valentine M, Mwinga K, Goldenberg R, Taha TE . Intrapartum antibiotic exposure and early neonatal, morbidity, and mortality in Africa. Pediatrics. 2009, 124: e137-44
Kajeepeta S, MacPhail C, Selin A, Gómez-Olivé FX, Gottert A, Kahn K, Hughes JP, Pettifor A . Gender attitudes and associations with sexual risk behaviors and outcomes among young South African women (HPTN 068).
Kaleebu P, Njai HF, Wang L, Jones N, Ssewanyana I, Richardson P, Kintu K, Emel L, Musoke P, Fowler MG, Ou SS, Jackson JB, Guay L, Andrew P, Baglyos L, Cao H; HPTN 027 protocol team . Immunogenicity of ALVAC-HIV vCP1521 in Infants of
HIV-1–Infected Women in Uganda (HPTN 027): The First
Pediatric HIV Vaccine Trial in Africa
. J Acquir Immune Defic Syndr. 2014, 65: 268-77
Kapadia SN, Wu C, Mayer KH, Wilkin TJ, Amico KR, Landovitz RJ, Andrade A, Chen YQ, Chege W, McCauley M, Gulick RM, Schackman BR . No change in health-related quality of life for at-risk U.S. women and men starting HIV pre-exposure prophylaxis (PrEP): Findings from HPTN 069/ACTG A5305. PLoS One. 2018, 13: e0206577
Kapiga S, Kelly C, Weiss S, Daley T, Peterson L, Leburg C, Ramjee G . Risk factors for incidence of sexually transmitted infections among women in South Africa, Tanzania, and Zambia: results from HPTN 055 study. Sex Transm Dis. 2009, 36: 199-206 PMID:19265734
Kapina M, Reid C, Roman K, Cyrus-Cameron E, Kwiecien A, Weiss S, Vermund SH . HIV Incidence Rates and Risk Factors for Urban Women in Zambia: Preparing for a Microbicide Clinical Trial. Sex Transm Dis. 2009, 36: 129-33
Karim QA, Baxter C, Karim SA . Topical microbicides--what's new?. J Acquir Immune Defic Syndr. 2013, 63: S144-9
Kashuba AD, Patterson KB, Dumond JB, Cohen MS . Pre-exposure prophylaxis for HIV prevention: how to predict success. Lancet. 2012, 379: 2409-11
Kawichai S, Celentano D, Srithanaviboonchai K, Wichajarn M, Pancharoen K, Chariyalertsak C, Visrutaratana S, Khumalo-Sakutukwa G, Sweat M, Chariyalertsak S; and The Project Accept Study Team . NIMH Project Accept (HPTN 043) HIV/AIDS Community Mobilization (CM) to Promote Mobile HIV Voluntary Counseling and Testing (MVCT) in Rural Communities in Northern Thailand: Modifications by Experience. AIDS Behav. 2012, 16: 1227-37
Kawichai S, Celentano DD, Chariyalertsak S, Visrutaratna S, Short O, Ruangyuttikarn C, Chariyalertsak C, Genberg B, Beyrer C . Community-based voluntary counseling and testing services in rural communities of Chiang Mai Province, Northern Thailand. AIDS Behav. 2007, 11: 770-7 PMID: 17503171
Keating SM, Bollinger RC, Quinn TC, Jackson JB, Carruth LM . Cross-clade T Lymphocyte Mediated Immunity to HIV-1: Implications for Vaccine Design and Immunodetection Assays. AIDS Res Hum Retroviruses. 2002, 18: 1067-79
Keating SM, Hanson D, Lebedeva M, Laeyendecker O, Ali-Napo NL, Owen SM, Stramer SL, Moore R, Norris PJ, Busch MP . Lower-sensitive and avidity modifications of the vitros anti-HIV1+2 assay for detection of recent HIV infections and incidence estimation. J Clin Microbiol. 2012, 50: 3968-76
Kevany S, Khumalo-Sakutukwa G, Murima O, Chingono A, Modiba P, Gray G, Van Rooyen H, Mrumbi K, Mbwambo J, Kawichai S, Chariyalertsak S, Chariyalertsak C, Paradza E, Mulawa M, Curran K, Fritz K, Morin SF . Health diplomacy the adaptation of global health interventions to local needs in sub-Saharan Africa and Thailand: evaluating findings from Project Accept (HPTN 043). BMC Public Health. 2012, 12: 459
Kevany S, Khumalo-Sakutukwa G, Singh B, Chingono A, Morin S, NIMH Project Accept Study Team . Global Health Diplomacy, Monitoring & Evaluation, and the Importance of Quality Assurance & Control: Findings from NIMH Project Accept (HPTN 043). PLoS One. 2016, 11: e0149335
Kevany S, Meintjes G, Rebe K, Maartens G, Cleary S . Clinical and financial burdens of secondary level care in a public sector antiretroviral roll-out setting (G. F. Jooste Hospital). S Afr Med J. 2009, 99: 320-5 PMID:19588792
Kevany S, Murima O, Singh B, Hlubinka D, Kulich M, Morin SF, Sweat M . Socio-economic status and health care utilization in rural Zimbabwe: findings from Project Accept (HPTN 043). J Public Health Africa. 2012, 3: 46-51
Kevany S, Sweat M, Singh B, Kulich M, Woelk G . Socio-economic status and health care utilization in rural Zimbabwe: Findings from Project Accept (HPTN 043). J of Public Health in Africa. 2012, 3: 46-51
Kevany S, Woelk G, Shade SB, Kulich M, Turan JM, Chingono A, Morin SF . Risk Factors for Physical Domestic Violence in a High-Prevalence HIV Setting: Findings from Project Accept Baseline Data (HPTN-043). J Public Health Africa. 2013, 4: e1
Khoza MN, Delany-Moretlwe S, Scorgie F, Hove J, Selin A, Imrie J, et al., Imrie J, Twine R, Kahn K, Pettifor A, MacPhail C . Men’s perspectives on the impact of female-directed cash transfers on gender relations: Findings from the HPTN 068 qualitative study. PLoS One. 2018, 13: e0207654
Khumalo-Sakutukwa G, Morin SF, Fritz K, Charlebois ED, Van Rooyen H, Chingono A, Modilba P, Mrumbi K, Visrutaratna S, Singh B, Sweat M, Celentano DD, Coates TJ . Project Accept (HPTN 043): A Community-Based Intervention to Reduce HIV Incidence in Populations at Risk for HIV in Sub-Saharan Africa and Thailand. JAIDS. 2008, 49: 422-31
Kilburn K, Hughes JP, MacPhail C, Wagner RG, Gomez-Olive FX, Kahn K, Pettifor A . Cash Transfers, Young Women's Economic Well-Being, and HIV Risk: Evidence from HPTN 068. AIDS Behav. 2019, 23: 1178-1194
Kilburn K, Ranganathan M, Stoner MCD, Hughes JP, MacPhail C, Agyei Y, Gomez-Olive FX, Kahn K, Pettifor A . Transactional sex and incident HIV infection in a cohort of young women from rural South Africa. AIDS. 2018, 32: 1669-1677
Kilburn KN, Pettifor A, Edwards JK, Selin A, Twine R, MacPhail C, Wagner R, Hughes JP, Wang J, Kahn K . Conditional cash transfers and the reduction in partner violence for young women: an investigation of causal pathways using evidence from a randomized experiment in South Africa (HPTN 068). J Int AIDS Soc. 2018, 21 Suppl 1
Kilewo C, Natchu UCM, Young A, Donnell D, Brown E, Read JS, Sharma U, Chi BH, Goldenberg R, Hoffman I, Taha TE, Fawzi WW . Hypertension in Pregnancy among HIV-Infected Women in Sub-Saharan Africa: Prevalence and Infant Outcomes.. African Journal of Reproductive Health. 2009, 13: 25-36 PMID:20690271
Kilmarx PH, Paxton L, Van Damme L, Rees h, Ramjee G, Laga M, Mâsse B . Need for a true placebo for vaginal microbicide efficacy trials. Lancet. 2003, 361: 785-786
Kim HN, Wang J, Hughes J, Coombs R, Sanchez J, Reid S, Delany-Moretlwe S, Cowan F, Fuchs J, Eshleman SH, Khaki L, McMahon MA, Siliciano RF, Wald A, Celum C . Effect of Acyclovir on HIV 1 Set Point among Herpes Simplex Virus Type 2 Seropositive Persons during Early HIV 1 Infection. J Infect Dis. 2010, 202: 734-8
Kintu K, Andrew P, Musoke P, Richardson P, Asiimwe-Kateera B, Nakyanzi T, Wang L, Fowler MG, Emel L, Ou SS, Baglyos L, Gurunathan S, Zwerski S, Jackson JB, Guay L . Feasibility and safety of ALVAC-HIV vCP1521 vaccine in HIV-exposed infants in Uganda: results from the first HIV vaccine trial in infants in Africa. J Acquir Immune Defic Syn. 2013, 63: 1-8
Kiriazova T, Go VF, Hershow RB, Hamilton EL, Sarasvita R, Bui Q, Lancaster KE, Dumchev K, Hoffman IF, Miller WC, Latkin CA . Perspectives of Clients and Providers on Factors Influencing Opioid Agonist Treatment Uptake among Hiv-Positive People Who Use Drugs in Indonesia, Ukraine, and Vietnam: Hptn 074 Study.. 2020
Kirkpatrick AR, Patel EU, Celum CL, Moore RD, Blankson JN, Mehta SH, Kirk GD, Margolick JB, Quinn TC, Eshleman SH, Laeyendecker O . Development and Evaluation of a Modified Fourth-Generation Human Immunodeficiency Virus Enzyme Immunoassay for Cross-Sectional Incidence Estimation in Clade B Populations. AIDS Res Hum Retroviruses. 2016, 32: 756-62
Kirkpatrick AR, Unsal AB, Blankson JN, Moore RD, Quinn TC, Hadigan C, Laeyendecker O . Weak HIV Antibody Responses in Perinatally Infected Young Adults: Weak HIV Antibody Responses in Perinatally Infected Adults. Pediatr Infect Dis J. 2017, 36: 1064-1066
Klevytska AM, Mracna MR, Guay L, Becker-Pergola G, Furtado M, Zhang, L, Jackson JB, and Eshleman SH . Analysis of length variation in the V1-V2 region of env in non-subtype B HIV-1 from Uganda. AIDS Res Hum Retroviruses. 2002, 18: 791-6
Koblin BA, Chesney MA, Husnik MJ, Bozeman S, Celum CL, Buchbinder S, Mayer K, McKirnan D, Judson FN, Huang Y, Coates TJ . High-Risk Behaviors Among Men Who Have Sex With Men in 6 US Cities: Baseline Data From the EXPLORE Study. Am J Public Health. 2003, 93: 926-32
Koblin BA, Heagerty P, Sheon A, Buchbinder S, Celum C, Douglas JM, Gross M, Marmor M, Mayer K, Metzger D, Seage G . Readiness of high-risk populations in the HIV Network for Prevention Trials to participate in HIV vaccine efficacy trials in the United States. AIDS. 1998, 12: 785-93
Koblin BA, Husnik MJ, Colfax G, Huang Y, Madison M, Mayer K, Barresi PJ, Coates TJ, Chesney MA, Buchbinder S . Risk factors for HIV infection among men who have sex with men. AIDS. 2006, 20: 731-9 PMID: 16514304
Koblin BA, Mayer KH, Eshleman SH, Wang L, Mannheimer S, del Rio C, Shoptaw S, Magnus M, Buchbinder S, Wilton L, Liu TY, Cummings V, Piwowar-Manning E, Fields SD, Griffith S, Elharrar V, Wheeler D, for the HPTN 061 Protocol Team . Correlates of HIV Acquisition in a Cohort of Black Men
Who Have Sex with Men in the United States: HIV
Prevention Trials Network (HPTN) 061
. PLoS One. 2013, 8: e70413
Konikoff J, Brookmeyer R, Longosz AF, Cousins MM, Celum C, Buchbinder SP, Seage GR 3rd, Kirk GD, Moore RD, Mehta SH, Margolick JB, Brown J, Mayer KH, Koblin BA, Justman JE, Hodder SL, Quinn TC, Eshleman SH, Laeyendecker O . Performance of a limiting-antigen avidity enzyme immunoassay for cross-sectional estimation of HIV incidence in the United States. PLoS One. 2013, 8: e82772
Kozlov AP, Shaboltas AV, Toussova OV, Verevochkin SV, Masse BR, Perdue T, Beauchamp G, Sheldon W, Miller WC, Heimer R, Ryder RW, Hoffman IF . HIV incidence and factors associated with HIV acquisition among injection drug users in St Petersburg, Russia. AIDS. 2006, 20: 901-6 PMID: 16549975
Kuder M, Goheen MJ, Dize L, Barnes M, Gaydos CA . Evaluation of a new website design for iwantthekit for chlamydia, gonorrhea, and trichomonas screening. Sex Transm Dis. 2015, 42: 243-245
Kumarasamy N, Flanigan TP, Mahajan AP, Carpenter CC, Mayer KH, Solomon S . Monitoring HIV treatment in the developing world. Lancet Infect Dis. 2002, 2: 656-7
Kumarasamy N, Mahajan AP, Flanigan TP, Hemalatha R, Mayer KH, Carpenter CCJ, Thyagarajan SP, Solomon S . Total lymphocyte count (TLC) is a useful tool for the timing of opportunistic infection prophylaxis in India and other resource-constrained countries. J Acquir Immune Defic Syndr. 2002, 31: 378-83
Kumarasamy N, Solomon S, Chaguturu SK, Mahajan AP, Flanigan TP, Balakrishnan P, Mayer KH . The safety, tolerability and effectiveness of generic antiretroviral drug regimens for HIV-infected patients in south India. AIDS. 2003, 17: 2267-9
Kumarasamy N, Solomon S, Flanigan TP, Hemalatha R, Thyagarajan SP, Mayer KH . Natural history of human immunodeficiency virus disease in southern India. Clin Infect Dis. 2003, 36: 79-85
Kumarasamy N, Vallabhaneni S, Cecelia AJ, Yepthomi T, Balakrishnan P, Saghayam S, Flanigan TP, Carpenter CC, Solomon S, Mayer KH . Reasons for modification of generic highly active antiretroviral therapeutic regimens among patients in southern India. J Acquir Immune Defic Syndr. 2006, 41: 53-8 PMID: 16340473
Kumwenda N, Hoffman I, Chirenje M, Kelly C, Coletti A, Ristow A, Martinson F, Brown J, Chilongozi D, Richardson B, Rosenberg Z, Padian N, Taha T . HIV incidence among women of reproductive age in Malawi and Zimbabwe. Sex Transm Dis. 2006, 33: 646-51 PMID: 16773032
Kumwenda NI, Taha TE, Hoover DR, Markakis D, Liomba GN, Chiphangwi JD, Celentano DD . HIV-1 incidence among male workers at a sugar estate in rural Malawi. J Acquir Immune Defic Syndr. 2001, 27: 202-8
Kumwenda NI, Taha TE, Hoover DR, Markakis D, Liomba GN, Chiphangwi JD, Celentano DD . Three Surveys of HIV-1 Prevalence and Risk Factors Among Men Working at a Sugar Estate in Malawi. Sex Transm Dis. 2002, 29: 366-371
Kuo I, Golin CE, Wang J, Haley DF, Hughes J, Mannheimer S, Justman J, Rompalo A, Frew PM, Adimora AA, Soto-Torres L, Hodder S; HPTN 064 Study Team, Hodder S, HPTN 064 Study Team . Substance use patterns and factors associated with changes over time in a cohort of heterosexual women at risk for HIV acquisition in the United States. Drug Alcohol Depend. 2014, 139: 93-9
Kurth AE, Celum C, Baeten JM, Vermund SH, Wasserheit JN . Combination HIV Prevention: Significance, Challenges, and Opportunities. Curr HIV/AIDS Rep. 2011, 8: 62-72
Kurth AE, Mayer K, Beauchamp G, McKinstry L, Farrior J, Buchacz K, Donnell D, Branson B, El-Sadr W; HPTN (065) TLC-Plus Study Team . Clinician practices and attitudes regarding early antiretroviral therapy in the United States. J Acquir Immune Defic Syndr. 2012, 61: e65-9
Lade JM, To EE, Hendrix CW, Bumpus NN . Discovery of Genetic Variants of the Kinases That Activate Tenofovir in a Compartment-specific Manner. EBioMedicine. 2015, 2: 1145-52